Pierre Fabre Dermatologie Starts Clinical Trials On A Beta-Blocker To Treat Severe Infantile Haemangioma

Pierre Fabre Dermatologie, specialised department of Pierre Fabre Laboratories, is proud to announce the launch of a set of clinical trials following the signature of an exclusive and worldwide licence agreement on July 10th 2008 with the University of Bordeaux.

More: continued here

Filed under: Clinical Trials on May 9th, 2009